Wearable and implantable devices for cardiovascular healthcare: from monitoring to therapy based on flexible and stretchable electronics

YJ Hong, H Jeong, KW Cho, N Lu… - Advanced Functional …, 2019 - Wiley Online Library
Cardiovascular disease is the leading cause of death and has dramatically increased in
recent years. Continuous cardiac monitoring is particularly important for early diagnosis and …

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

H Calkins, G Hindricks, R Cappato, YH Kim… - Ep …, 2018 - academic.oup.com
AFL atrial flutter AH arterial hypertension ANS autonomic nervous system APD action
potential duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation …

JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias

A Nogami, T Kurita, H Abe, K Ando, T Ishikawa… - Circulation …, 2021 - jstage.jst.go.jp
Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial

JG Andrade, J Champagne, M Dubuc, MW Deyell… - Circulation, 2019 - Am Heart Assoc
Background: Advanced generation ablation technologies have been developed to achieve
more effective pulmonary vein isolation (PVI) and minimize arrhythmia recurrence after atrial …

[HTML][HTML] Low complication rates using high power (45–50 W) for short duration for atrial fibrillation ablations

RA Winkle, S Mohanty, RA Patrawala, RH Mead… - Heart rhythm, 2019 - Elsevier
Background Many centers use radiofrequency (RF) energy at 25–35 W for 30–60 seconds.
There is a safety concern about using higher power, especially on the posterior wall …

Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial

A Natale, VY Reddy, G Monir, DJ Wilber… - Journal of the American …, 2014 - jacc.org
Background: Catheter ablation is important for treatment of paroxysmal atrial fibrillation
(PAF). Limited animal and human studies suggest a correlation between electrode-tissue …

Randomized, controlled trial of the safety and effectiveness of a contact force–sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the …

VY Reddy, SR Dukkipati, P Neuzil, A Natale… - Circulation, 2015 - Am Heart Assoc
Background—Contact force (CF) is a major determinant of lesion size and transmurality and
has the potential to improve efficacy of atrial fibrillation ablation. This study sought to …

EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation

J Kautzner, P Neuzil, H Lambert, P Peichl, J Petru… - Ep …, 2015 - academic.oup.com
Aims A challenge of pulmonary vein isolation (PVI) in catheter ablation for paroxysmal atrial
fibrillation (PAF) is electrical reconnection of the PV. EFFICAS I showed correlation between …

Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study

P Neuzil, VY Reddy, J Kautzner, J Petru… - Circulation …, 2013 - Am Heart Assoc
Background—Pulmonary vein isolation is the most prevalent approach for catheter ablation
of paroxysmal atrial fibrillation. Long-term success of the procedure is diminished by …

Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap …

KH Kuck, BA Hoffmann, S Ernst… - Circulation …, 2016 - Am Heart Assoc
Background—Ablation of atrial fibrillation (AF) is an established treatment option for
symptomatic patients. It is not known whether complete pulmonary vein isolation (PVI) is …